These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154 [TBL] [Abstract][Full Text] [Related]
24. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro. Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118 [TBL] [Abstract][Full Text] [Related]
25. Interstitial fluid pressure: A novel biomarker to monitor photo-induced drug uptake in tumor and normal tissues. Cavin S; Wang X; Zellweger M; Gonzalez M; Bensimon M; Wagnières G; Krueger T; Ris HB; Gronchi F; Perentes JY Lasers Surg Med; 2017 Oct; 49(8):773-780. PubMed ID: 28544068 [TBL] [Abstract][Full Text] [Related]
26. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT). Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380 [TBL] [Abstract][Full Text] [Related]
27. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells. Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562 [TBL] [Abstract][Full Text] [Related]
28. Co-occurring Mutations of Tumor Suppressor Genes, Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305 [No Abstract] [Full Text] [Related]
29. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma. Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086 [TBL] [Abstract][Full Text] [Related]
30. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma. Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002 [TBL] [Abstract][Full Text] [Related]
31. Chemo-manipulation of tumor blood vessels by a metal-based anticancer complex enhances antitumor therapy. Riedel T; Cavin S; van den Bergh H; Krueger T; Liaudet L; Ris HB; Dyson PJ; Perentes JY Sci Rep; 2018 Jul; 8(1):10263. PubMed ID: 29980753 [TBL] [Abstract][Full Text] [Related]
32. Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities. Wang X; Gronchi F; Bensimon M; Mercier T; Decosterd LA; Wagnières G; Debefve E; Ris HB; Letovanec I; Peters S; Perentes JY Lasers Surg Med; 2015 Dec; 47(10):807-16. PubMed ID: 26415084 [TBL] [Abstract][Full Text] [Related]
33. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma. Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744 [TBL] [Abstract][Full Text] [Related]
34. A preclinical model to investigate the role of surgically-induced inflammation in tumor responses to intraoperative photodynamic therapy. Davis RW; Papasavvas E; Klampatsa A; Putt M; Montaner LJ; Culligan MJ; McNulty S; Friedberg JS; Simone CB; Singhal S; Albelda SM; Cengel KA; Busch TM Lasers Surg Med; 2018 Jul; 50(5):440-450. PubMed ID: 29799130 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells. Shukuya T; Oyanagi J; Serizawa M; Watanabe M; Yamamoto N; Koh Y Anticancer Res; 2020 Apr; 40(4):1867-1874. PubMed ID: 32234874 [TBL] [Abstract][Full Text] [Related]
36. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma. Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948 [TBL] [Abstract][Full Text] [Related]
37. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells. Zanellato I; Colangelo D; Osella D Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341 [TBL] [Abstract][Full Text] [Related]